| Ytd | 17.20% | |
| 1y | -17.42% |
| Open | 2.12 | Prev Close | 2.24 | Low | 2.12 | High | 2.20 | Mkt Cap | 20.40M |
| Vol | 45.02K | Avg Vol | 108.02K | EPS | -1.86 | P/E | -1.20 | Forward P/E | -1.20 |
| Beta | 0.79 | Short Ratio | 1.79 | Inst. Own | 9.07% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 3.35 | 200-d Avg | 3.30 | 1yr Est | 14.00 |
LSTA News
Lisata Therapeutics stock fell after hours after updating investors on its pending acquisition and t
Gainers China Pharma Holding (AMEX:CPHI) shares increased by 713.2% to $7.4 during Tuesday's re
Gainers Jupiter Neurosciences (NASDAQ:JUNS) stock rose 36.4% to $0.23 during Tuesday's pre-mark
Gainers AVITA Medical (NASDAQ:RCEL) stock moved upwards by 11.1% to $4.9 during Thursday's afte
SAN DIEGO, June 26, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating Lisata Therapeuti
Bala Cynwyd, Pennsylvania--(Newsfile Corp. - June 15, 2026) - Law office of Brodsky & Smith announce
Lisata Therapeutics Inc (NASDAQ:LSTA, FRA:8NE) has agreed to be acquired by privately held Kuva Labs
Lisata stockholders to receive $4.00 per share in cash at closing, plus one non-tradeable contingent
Lisata stockholders to receive $4.00 per share in cash at closing, plus one non-tradeable contingent
Lisata Therapeutics Inc (NASDAQ:LSTA, FRA:8NE) has agreed to be acquired by privately held Kuva Labs
Taylor Morrison Home soared 23.28% to $72.12 in pre-market trading after Berkshire Hathaway announce
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
NEW YORK, May 04, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde and
NEW YORK--(BUSINESS WIRE)--LSTA, the trade association for the U.S. corporate lending market, today
Lisata Therapeutics Inc (NASDAQ:LSTA, FRA:8NE), a clinical-stage pharmaceutical company developing t
MILWAUKEE, March 9, 2026 /PRNewswire/ -- Ademi LLP is investigating Lisata (NASDAQ: LSTA) for possib
Lisata Therapeutics Inc (NASDAQ:LSTA, FRA:8NE), a clinical-stage pharmaceutical company developing t
Lisata Therapeutics (LSTA) surged 20.3% to $5.03 in pre-market trading after agreeing to be taken pr
Lisata Therapeutics (LSTA) surged 20.3% to $5.03 in pre-market trading after agreeing to be taken pr
Each Lisata stockholder to receive $5.00 per share in cash payable at closing plus one contingent va
Each Lisata stockholder to receive $5.00 per share in cash payable at closing plus one contingent va
Lisata Therapeutics (NASDAQ: LSTA - Get Free Report) will likely be issuing its Q4 2025 results befo
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
Lisata Therapeutics Inc (NASDAQ:LSTA, FRA:8NE) said it has mutually terminated a licensing and colla
Lisata regains full development rights to certepetide in the Greater China Region Lisata regains ful
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t
Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report q
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn
Monday saw 196 companies set new 52-week lows.
New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 12
Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.